Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Altheia Science logo — Altheia Science develops treatments for autoimmune diseases...

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative tools. Founded by renowned Italian scientists.

Founded 2017 Italy Italy 6 employees Series A Total: $11.00M Biotechnology, Health Care +1

General Information

Company Name Altheia Science
Founded Year 2017
Location Italy Italy
Employees 6
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Altheia Science. To contact Altheia Science, visit altheiascience.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Altheia Science compare?

A PDF of Altheia Science and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Altheia Science soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Altheia Science

Altheia Science is a cutting-edge biotechnology startup headquartered in Italy, founded in 2017 by renowned Italian scientists Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD along with AurorA-TT. The company specializes in developing innovative treatments for autoimmune diseases and cancer using pioneering therapeutic tools. Its approach involves the modulation of PD-L1 expression at the molecular and protein level, aiming to achieve tangible and durable benefits for each patient. Altheia Science secured a significant $11.00M Series A investment on 24 September 2018 from Rottapharm Biotech. With its groundbreaking approach and strong backing, Altheia Science is poised to make a substantial impact in the fields of biotechnology and healthcare.

Business keywords: gene therapy, autoimmunity, autoimmune diseases, cancer, cell therapy, gene editing, PD-L1 modulation, lentiviral vector, hematopoietic stem cells, innovation, Italian biotech company, treatment development, immunotherapy, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $11.00M 1
Rottapharm Biotech
Rottapharm Biotech
24 Sep 2018

Altheia Science Alternatives & Competitors

View All Alternatives
Altheia Science vs
Genenta Science (Nasdaq: GNTA)
Genenta Science (Nasdaq: GNTA) Italy

Genenta is a clinical stage immuno-oncology company

Post-IPO Secondary
25 employees
Biotechnology, Health Care
Altheia Science vs
Celularity Inc.
Celularity Inc. United States

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Deg...

Post-IPO Equity
171 employees
Biotechnology, Health Care
Altheia Science vs
Edity Therapeutics
Edity Therapeutics Israel

Using human immune cells to deliver therapeutic proteins

Seed
22 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative tools. Founded by renowned Italian scientists.
Altheia Science was founded in 2017.
Altheia Science is headquartered in Italy.
Altheia Science operates in Biotechnology, Health Care and Health and Wellness. Its work centres on gene therapy, autoimmunity, autoimmune diseases and cancer.
Altheia Science has approximately 6 employees.
Altheia Science has completed 1 funding round, raising a total of $11.00M. The latest funding stage is Series A.
Top alternatives and competitors to Altheia Science include Genenta Science (Nasdaq: GNTA), Celularity Inc., Edity Therapeutics , American Gene Technologies® International Inc., Rebirthel Co.,Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Altheia Science and Genenta Science (Nasdaq: GNTA) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Altheia Science, https://bouncewatch.com/company/altheia-science, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout